Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications

Jayant A. Talwalkar, Meng Yin, Jeff L. Fidler, Schuyler O. Sanderson, Patrick S. Kamath, Richard L. Ehman

Research output: Contribution to journalReview articlepeer-review

255 Scopus citations


Chronic liver disease and cirrhosis remains a major public health problem worldwide. While the majority of complications from chronic liver disease result from progressive hepatic fibrosis, the available diagnostic tests used in clinical practice are not sensitive or specific enough to detect occult liver injury at early or intermediate stages. While liver biopsy can stage the extent of fibrosis at diagnosis, its utility as a tool for longitudinal monitoring will be limited at the population level. To date, a number of methods including serum marker panels and ultrasound-based transient elastrography have been proposed for the non-invasive identification of hepatic fibrosis. Novel techniques including magnetic resonance (MR) spectroscopy, diffusion weighted MR, and MR elastography have also emerged for detecting fibrosis. In contrast to other non-invasive methods, MR imaging holds the promise of providing functional and biological information about hepatic pathophysiology as it relates to the natural history and future treatment of hepatic fibrosis.

Original languageEnglish (US)
Pages (from-to)332-342
Number of pages11
Issue number1
StatePublished - Jan 2008

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications'. Together they form a unique fingerprint.

Cite this